With our FLT3 binder 4G8, we also observed downmodulation of FLT3 expression on AML and B-ALL cells [12], but even high mAb concentrations did not reduce antigen expression by more than 30%–40%. The gene discussed is FLT3; the disease is acute lymphoblastic leukemia.